Stay updated on Psilocybin for Major Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Major Depression Clinical Trial page.

Latest updates to the Psilocybin for Major Depression Clinical Trial page
- CheckyesterdayChange DetectedA site-wide banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer's ClinicalTrials.gov revision identifier updates from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 Forbidden error page.SummaryDifference0.2%

- Check36 days agoChange Detected403 Forbidden error is rendered, replacing the full study record and related content with a generic error page. This blocks access to the study details, locations, and data submission information the page normally provides.SummaryDifference19%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This is a software release update and does not alter the study information or its presentation.SummaryDifference0.1%

Stay in the know with updates to Psilocybin for Major Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Major Depression Clinical Trial page.